Company Overview

Sotera Health Company (SHC) is a global healthcare services company that provides mission‑critical sterilization, laboratory testing, and advisory services primarily to the medical device, pharmaceutical, biotechnology, and food safety industries. The company operates within the broader healthcare services and life sciences infrastructure sectors, focusing on ensuring product safety, regulatory compliance, and patient protection across the healthcare supply chain. Its services are typically embedded early in customers’ product development and manufacturing lifecycles, creating long-term, recurring customer relationships.

The company’s primary revenue drivers are outsourced sterilization services, microbiological and analytical laboratory testing, and radiation-based technologies used in healthcare and industrial applications. Sotera Health’s strategic positioning is based on high regulatory barriers to entry, specialized technical expertise, and global scale. The company traces its roots to businesses established decades ago, including Sterigenics and Nordion, and was consolidated into its current structure prior to its public listing. Sotera Health became a publicly traded company in 2020, expanding its access to capital to support growth and operational investments.

Business Operations

Sotera Health operates through three core business segments: Sterigenics, Nelson Labs, and Nordion. Sterigenics provides outsourced terminal sterilization services using ethylene oxide, gamma irradiation, e-beam, and other modalities, serving medical device manufacturers and pharmaceutical companies. Nelson Labs offers microbiology and analytical chemistry testing, advisory services, and regulatory support for medical devices, pharmaceuticals, and biologics. Nordion supplies gamma irradiation technologies and cobalt‑60 used in medical sterilization, cancer treatment, and industrial applications.

Revenue is generated through long-term service contracts, recurring testing and validation work, and the supply of radiation technologies. The company operates a capital-intensive asset base that includes sterilization facilities, laboratories, and radiation sources. Sotera Health maintains a combination of wholly owned subsidiaries and operating entities across its segments, with no material joint ventures disclosed publicly. Its operations are subject to extensive regulatory oversight, particularly from healthcare and environmental authorities.

Strategic Position & Investments

Sotera Health’s strategic direction emphasizes organic growth through capacity expansion, operational efficiency, and deeper integration with customers’ quality and compliance processes. Growth initiatives include expanding sterilization capacity, investing in laboratory automation and digital quality systems, and enhancing advisory services that support regulatory submissions and product approvals. The company has also focused on environmental, safety, and compliance investments, particularly related to ethylene oxide emissions controls.

The company’s portfolio includes the wholly owned subsidiaries Sterigenics, Nelson Labs, and Nordion, which collectively represent its core operating platform. Sotera Health has historically pursued selective acquisitions to enhance technical capabilities and geographic reach, although large transformational acquisitions have been limited since its public listing. Emerging areas of focus include advanced sterilization technologies, increased use of irradiation in healthcare applications, and expanded laboratory services supporting biologics and combination products.

Geographic Footprint

Sotera Health operates on a global scale, with a significant presence in North America, Europe, and Asia-Pacific. The company is headquartered in North America and maintains sterilization facilities, laboratories, and technology operations across multiple continents. Its customers include multinational medical device and pharmaceutical companies that require consistent service delivery across regions.

International operations are a critical component of Sotera Health’s business model, enabling it to support global supply chains and regulatory requirements in different jurisdictions. The company’s geographic diversification helps mitigate regional demand fluctuations while increasing exposure to growth in international healthcare markets, particularly in Europe and select Asia-Pacific countries.

Leadership & Governance

Sotera Health is led by an executive team with experience in healthcare services, industrial operations, and regulated industries. The company’s leadership emphasizes operational excellence, regulatory compliance, and long-term value creation through disciplined capital allocation and risk management. Governance practices are aligned with U.S. public company standards following its initial public offering.

Key executives include:

• Michael Petras – President and Chief Executive Officer
• Garth Westphal – Chief Financial Officer
• Sam Ratnam – Chief Operating Officer
• Patti McCarroll – Chief Human Resources Officer
• Tom Browne – Chief Legal and Compliance Officer